Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jan;12(1):e200363.
doi: 10.1212/NXI.0000000000200363. Epub 2024 Dec 26.

Ten Years of Neurology® Neuroimmunology & Neuroinflammation: Decade in Review

Affiliations
Editorial

Ten Years of Neurology® Neuroimmunology & Neuroinflammation: Decade in Review

Josep Dalmau et al. Neurol Neuroimmunol Neuroinflamm. 2025 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

J. Dalmau is editor of N2, holds patents for the use of NMDAR, GABABR, GABAAR, DPPX, and IgLON5 as autoantibody tests and receives royalties from the use of these tests. M.C. Dalakas is an associate editor of N2, received speaker honorarium from Grifols, CSL, Sanofi and UCB; has received consultation for serving in the Scientific advisory Board or DSMB for Argenx, Octapharma, Kyverna and Dysimmune diseases Foundation; and serves as deputy editor in Therapeutic Advances of Neurology and on the editorial board for Practice Update (Elsevier). D.L. Kolson is an associate editor of N2, F. Paul is an Associate Editor of N2, and A.-K. Pröbstel is an associate editor of N2. S. Zamvil is deputy editor of N2. Go to Neurology.org/NN for full disclosures.

References

    1. Graus F, Vogrig A, Muniz-Castrillo S, et al. . Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1014. doi:10.1212/NXI.0000000000001014 - DOI - PMC - PubMed
    1. Graus F, Delattre JY, Antoine JC, et al. . Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135-1140. doi:10.1136/jnnp.2003.034447 - DOI - PMC - PubMed
    1. Vogrig A, Fouret M, Joubert B, et al. . Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors. Neurol Neuroimmunol Neuroinflamm. 2019;6(6):e604. doi:10.1212/NXI.0000000000000604 - DOI - PMC - PubMed
    1. Dalmau J, Graus F, Villarejo A, et al. . Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127(pt 8):1831-1844. doi:10.1093/brain/awh203 - DOI - PubMed
    1. Farina A, Villagran-Garcia M, Ciano-Petersen NL, et al. . Anti-Hu antibodies in patients with neurologic side effects of immune checkpoint inhibitors. Neurol Neuroimmunol Neuroinflamm. 2023;10(1):e200058. doi:10.1212/NXI.0000000000200058 - DOI - PMC - PubMed

Publication types

LinkOut - more resources